Search clinical trials for: Modulation of FiO2
Total 10000 results
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsCompletedProstate CancerUnited States
-
AllerganCompletedChoroidal Neovascularization | Age-Related MaculopathyUnited States, Australia, Philippines
-
Deutsches Herzzentrum MuenchenCompletedMyocardial Infarction | Coronary DiseaseGermany, Italy
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Catholic University of the Sacred HeartCompleted
-
Karamanoğlu Mehmetbey UniversityKaraman Training and Research HospitalCompleted
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Assiut UniversityNot yet recruiting
-
Qingdao Central HospitalRecruiting
-
VA Office of Research and DevelopmentCompletedDepression | Chronic Pain | Anxiety | Traumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
University of RochesterActive, not recruitingMultiple MyelomaUnited States
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | Deletion 17P SyndromeItaly
-
GlaxoSmithKlineActive, not recruiting
-
CorMedixDavita Clinical Research; JMI Laboratories; Spectra Clinical Research; Frenova... and other collaboratorsCompletedKidney Failure, Chronic | Catheter-Related InfectionsUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Japan, Spain, Italy, Poland, France, Israel, Turkey, Korea, Republic of, Greece, Russian Federation, China, United Kingdom, New Zealand, Brazil, Czechia, Germany
-
Fernando SanchezHospital General Universitario de Castellón; Hospital Universitario de la PlanaTerminated
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
McMaster UniversityHamilton Health Sciences Corporation; Population Health Research InstituteCompletedAtherosclerotic Disease | Perioperative BleedingCanada
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
Ohr Pharmaceutical Inc.UnknownAge-related Macular DegenerationUnited States
-
TakedaCompletedVenous ThromboembolismUnited States, Canada
-
Novartis PharmaceuticalsCompletedMacular Edema | Visual Impairment | Branch Retinal Vein OcclusionGermany, United Kingdom, Hungary, Poland, Czech Republic
-
Oregon Health and Science UniversityGenentech, Inc.CompletedAge-Related Macular DegenerationUnited States
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Daratumumab | Carfilzomib | Pomalidomide
-
PETHEMA FoundationBristol-Myers Squibb; Sanofi; Adknoma; Start from scratchNot yet recruitingNewly Diagnosed Multiple MyelomaSpain
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Yonsei UniversityRecruitingMetastatic Colorectal CancerKorea, Republic of
-
Keymed Biosciences Co.LtdRecruitingLymphoma | Multiple MyelomaChina
-
Ascentage Pharma Group Inc.Recruiting
-
GlaxoSmithKlineIQVIA Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Cairo UniversityCompletedDiabetic Macular EdemaEgypt
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
McMaster UniversityTerminatedVenous Thromboembolism | Spinal Cord InjuriesCanada
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
Capital Medical UniversityCompleted
-
University of SydneyAllerganCompletedDiabetes | Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Macular OedemaAustralia
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
GlaxoSmithKlineCompletedAcute HIT II (Heparin-induced Thrombocytopenia Type II)
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Medical University of ViennaCompletedAge-Related Macular Degeneration | Neovascularization, ChoroidalAustria
-
PfizerCompletedRenal Cell CarcinomaFrance, Belgium, Hungary, Taiwan, United States, Australia, Spain, Hong Kong, Malaysia, Serbia, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation and more
-
Palle Bekker JeppesenTauroPharmUnknownCatheter-related Bloodstream Infection (CRBSI) NosDenmark
-
Janssen Research & Development, LLCTerminatedPneumonia, Bacterial | Pneumonia, Ventilator-Associated | Nosocomial Infection | Community-Acquired InfectionsPoland, Ukraine, United States, Argentina, Colombia, Brazil, Panama, Lithuania, Mexico, Latvia
-
Chinese University of Hong KongPeking University First Hospital; Obstetrics & Gynecology Hospital of Fudan... and other collaboratorsRecruiting
-
Assistance Publique - Hôpitaux de ParisCompleted